Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 4Sanofi-Aventis Canada Inc.
01 42045433
01 4Enoxaparin Sodium
01 4Solution
01 42011-06-25
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2011-06-25
Date Granted : 2002-07-30
Brand Name : LOVENOX
Patent Number : 2045433
Filing Date : 1991-06-25
Strength per Unit : 100mg / ml (30mg / 0.3ml)
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2011-06-25
Date Granted : 2002-07-30
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2011-06-25
Date Granted : 2002-07-30
Brand Name : LOVENOX
Patent Number : 2045433
Filing Date : 1991-06-25
Strength per Unit : 100mg / ml (40mg / 0.4ml, 60mg / 0.6ml, 80mg / 0.8
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2011-06-25
Date Granted : 2002-07-30
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2011-06-25
Date Granted : 2002-07-30
Brand Name : LOVENOX
Patent Number : 2045433
Filing Date : 1991-06-25
Strength per Unit : 100mg / ml (300mg / 3ml)
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2011-06-25
Date Granted : 2002-07-30
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2011-06-25
Date Granted : 2002-07-30
Brand Name : LOVENOX HP
Patent Number : 2045433
Filing Date : 1991-06-25
Strength per Unit : 150mg / ml (90mg / 0.6ml, 120mg / 0.8ml & 150mg /
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2011-06-25
Date Granted : 2002-07-30
LOOKING FOR A SUPPLIER?